KilgourMD Brings N1 Delivery Technology to a New Scalp Serum
KilgourMD’s reformulated Treatment Scalp Serum brings AndroLock, developed with N1 Life’s peptide delivery technology, to market.
From collaboration to product launch
In January 2026, N1 Life and US scalp-care brand KilgourMD announced a collaboration to develop scalp formulations using AbsoTide™ peptide delivery technology. In November, KilgourMD introduced its reformulated Treatment Scalp Serum, featuring AndroLock™, developed together by the two companies. [1, 2]
Pairing saw palmetto with peptide delivery
Built on N1 Life’s AbsoTide technology, AndroLock combines saw palmetto extract with a delivery peptide designed for the scalp. Saw palmetto is a botanical active already used in scalp care; the peptide is designed to help deliver it into the scalp. [1, 2]
In its launch announcement, KilgourMD reported that a human skin microscopy study showed a 47% increase in saw palmetto delivery with the peptide. The company also described changes associated with hair-growth pathways in a gene-expression study using human scalp explants. [1]
Looking ahead
From joint development to a product launch, N1 Life is proud to take this step with KilgourMD. We congratulate the KilgourMD team on its new products and look forward to continuing our collaboration to bring delivery science to further innovations in scalp care.
Explore N1 Life’s delivery programs.